Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$0.62
+0.83%
Mkt Cap $37.23M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
Implied Upside
+1835.5%
Consensus $12.00 vs current $0.62
NASDAQ·Healthcare·Biotechnology
$0.62
+0.83%
Mkt Cap $37.23M
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
+1835.5%
Consensus $12.00 vs current $0.62